|
GeneGo Incorporated. founded in 2000 and based in Saint Joseph, Michigan, develops systems that support the analysis of human biology and medicinal chemistry experimental data. The firm is known for its MetaCore (TM) products, which support drug candidate selection and validation processes. The technology's high-throughput data parsers and visualization tools streamline the identification of disease state molecular biomarkers. The MetaCore systems reference the company's MetaBase (TM) human biology database. GeneGo also offers clients the MetaDrug (TM) toxicogenomics platform, employed in evaluating novel small molecules and compounds. The company serves pharmaceutical firms and academic laboratories. It provides clients with tissue and disease modeling, data integration, drug target validation, custom pathway mapping, and other services. Working with Invitrogen (TM), the company has launched the i-PATH service, which provides researchers with free access to 225 human cell signaling and metabolic pathway maps. Antibodies, DNA molecules, and other Invitrogen products are linked to map objects. The firm was founded by Dr. Tatiana Nikolskaya, formerly a wet lab molecular biologist at the University of Chicago. The company maintains business offices in San Diego, California and Munich, Germany. Additional research facilities are based in Moscow, Russia.
|